The mammalian MAPK/ERK pathway exhibits properties of a negative feedback amplifier
- PMID: 21177493
- DOI: 10.1126/scisignal.2001212
The mammalian MAPK/ERK pathway exhibits properties of a negative feedback amplifier
Abstract
Three-tiered kinase modules, such as the Raf-MEK (mitogen-activated or extracellular signal-regulated protein kinase kinase)-ERK (extracellular signal-regulated kinase) mitogen-activated protein kinase pathway, are widespread in biology, suggesting that this structure conveys evolutionarily advantageous properties. We show that the three-tiered kinase amplifier module combined with negative feedback recapitulates the design principles of a negative feedback amplifier (NFA), which is used in electronic circuits to confer robustness, output stabilization, and linearization of nonlinear signal amplification. We used mathematical modeling and experimental validation to demonstrate that the ERK pathway has properties of an NFA that (i) converts intrinsic switch-like activation kinetics into graded linear responses, (ii) conveys robustness to changes in rates of reactions within the NFA module, and (iii) stabilizes outputs in response to drug-induced perturbations of the amplifier. These properties determine biological behavior, including activation kinetics and the response to drugs.
Similar articles
-
Positive- and negative-feedback regulations coordinate the dynamic behavior of the Ras-Raf-MEK-ERK signal transduction pathway.J Cell Sci. 2009 Feb 1;122(Pt 3):425-35. doi: 10.1242/jcs.036319. J Cell Sci. 2009. PMID: 19158341
-
Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.J Pharmacol Exp Ther. 2009 Jun;329(3):1063-70. doi: 10.1124/jpet.108.147306. Epub 2009 Mar 3. J Pharmacol Exp Ther. 2009. PMID: 19258520
-
Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.Cancer Res. 2004 Jul 1;64(13):4637-47. doi: 10.1158/0008-5472.CAN-03-2645. Cancer Res. 2004. PMID: 15231676
-
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.Oncogene. 2007 May 14;26(22):3291-310. doi: 10.1038/sj.onc.1210422. Oncogene. 2007. PMID: 17496923 Review.
-
MEK in cancer and cancer therapy.Pharmacol Ther. 2014 Feb;141(2):160-71. doi: 10.1016/j.pharmthera.2013.10.001. Epub 2013 Oct 9. Pharmacol Ther. 2014. PMID: 24121058 Review.
Cited by
-
A systems biology analysis of long and short-term memories of osmotic stress adaptation in fungi.BMC Res Notes. 2012 May 25;5:258. doi: 10.1186/1756-0500-5-258. BMC Res Notes. 2012. PMID: 22631601 Free PMC article.
-
The co-repressor SMRT delays DNA damage-induced caspase activation by repressing pro-apoptotic genes and modulating the dynamics of checkpoint kinase 2 activation.PLoS One. 2013 May 17;8(5):e59986. doi: 10.1371/journal.pone.0059986. Print 2013. PLoS One. 2013. PMID: 23690919 Free PMC article.
-
Complexity of receptor tyrosine kinase signal processing.Cold Spring Harb Perspect Biol. 2013 Aug 1;5(8):a009043. doi: 10.1101/cshperspect.a009043. Cold Spring Harb Perspect Biol. 2013. PMID: 23906711 Free PMC article. Review.
-
BRAF V600E Mutation in Triple-Negative Breast Cancer: A Case Report and Literature Review.Oncol Res Treat. 2022;45(1-2):54-61. doi: 10.1159/000520453. Epub 2021 Nov 24. Oncol Res Treat. 2022. PMID: 34818649 Free PMC article. Review.
-
Ultrasensitive response motifs: basic amplifiers in molecular signalling networks.Open Biol. 2013 Apr 24;3(4):130031. doi: 10.1098/rsob.130031. Open Biol. 2013. PMID: 23615029 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
